Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5094831 | 0.97 | NPSR1 (0.67) | NPSR1ALDH1A1KMT2APOLBNPC1 | |
| Bromide SCHEMBL31210017 | 0.97 | NPSR1 (0.67) | NPSR1ALDH1A1KMT2APOLBNPC1 | |
| Methylamine SCHEMBL10655180 | 0.92 | NPSR1 (0.61) | NPSR1ALDH1A1KMT2APOLBNPC1 | |
| SCHEMBL27979506 | 0.92 | NPSR1 (0.61) | NPSR1ALDH1A1KMT2APOLBNPC1 | |
| Carbamic Acid SCHEMBL11376840 | 0.92 | NPSR1 (0.61) | NPSR1ALDH1A1KMT2APOLBNPC1 | |
| SCHEMBL28228964 | 0.92 | NPSR1 (0.61) | NPSR1ALDH1A1KMT2APOLBNPC1 | |
| Dimethylamine SCHEMBL10653757 | 0.90 | NPSR1 (0.58) | NPSR1ALDH1A1KMT2APOLBNPC1 | |
| Carbamic Acid SCHEMBL10488831 | 0.90 | NPSR1 (0.58) | NPSR1ALDH1A1KMT2APOLBNPC1 | |
| SCHEMBL11682083 | 0.86 | NPSR1 (0.54) | NPSR1ALDH1A1KMT2APOLBNPC1 | |
| Diphenylamine SCHEMBL10650342 | 0.86 | NPSR1 (0.54) | NPSR1ALDH1A1KMT2APOLBNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 721 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119119156-A | Bridged artificial nucleic acid ALNA | 田边三菱制药株式会社 | 2024-12-13 | — | — | CN | claimed |
| EP-2609107-B1 | BLOCK SYNTHESIS OF OLIGORIBONUCLEOTIDES | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING / MCGILL UNIV (CA) | 2024-12-11 | — | — | EP | claimed |
| CN-117964673-A | Bridged artificial nucleic acid ALNA | 田边三菱制药株式会社 | 2024-05-03 | — | — | CN | claimed |
| CN-114606402-B | Rare earth ore leaching mother liquor continuous treatment system and treatment method thereof | 龙岩市稀土开发有限公司 | 2023-09-01 | — | — | CN | claimed |
| CN-114606402-A | Continuous treatment system and method for rare earth ore leaching mother liquor | 龙岩市稀土开发有限公司 | 2022-06-10 | — | — | CN | claimed |
| US-20210300954-A1 | IONIC TAGS FOR SYNTHESIS OF OLIGORIBONUCLEOTIDES | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIV (CA) | 2021-09-30 | — | — | US | claimed |
| CN-112996522-A | Bridged artificial nucleic acid ALNA | 田边三菱制药株式会社 | 2021-06-18 | — | — | CN | claimed |
| US-20190161491-A1 | METHODS FOR THE CHEMICAL SYNTHESIS OF PYRROLE-LINKED BIVALENT COMPOUNDS, AND COMPOSITIONS THEREOF | AVEKSHAN, LLC. | 2019-05-30 | — | — | US | claimed |
| US-20180072747-A1 | METHODS FOR THE CHEMICAL SYNTHESIS OF PYRROLE-LINKED BIVALENT COMPOUNDS, AND COMPOSITIONS THEREOF | AVEKSHAN, LLC. | 2018-03-15 | — | — | US | claimed |
| EP-3270916-A1 | METHODS FOR THE CHEMICAL SYNTHESIS OF PYRROLE-LINKED BIVALENT COMPOUNDS, AND COMPOSITIONS THEREOF | Avekshan LLC (US) | 2018-01-24 | — | — | EP | claimed |
| US-20020052337-A1 | Composition and method for inhibiting platelet aggregation | NORTH CAROLINA, UNIVERSITY OF | 2002-05-02 | — | — | US | claimed |
| WO-2002016381-A2 | COMPOSITION AND METHOD FOR INHIBITING PLATELET AGGREGATION | INSPIRE PHARMACEUTICALS, INC. (US) | 2002-02-28 | — | — | WO | claimed |
| EP-0749424-B1 | NAPHTHALENE DERIVATIVES AS PROSTAGLANDIN I2 AGONISTS | FUJISAWA PHARMACEUTICAL CO (JP) | 2001-09-12 | — | — | EP | claimed |
| US-5660994-A | SOLUBILIZING TO OBTAIN ALPHA-HELICAL MIDDLE PIECES OF NON-SECRETED INTERMEDIATE FILAMENT PROTEINS; REACTING WITH ANTIBODY; BINDING IDENTIFIES CELLULAR ORIGIN OF PROTEIN MATERIAL | PROGEN BIOTECHNIK GMBH (DE) | 1997-08-26 | — | — | US | claimed |
| EP-0749424-A1 | NAPHTHALENE DERIVATIVES AS PROSTAGLANDIN I2 AGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-12-27 | — | — | EP | claimed |
| WO-1996034604-A1 | INHIBITION OF INTRACELLULAR ACIDIFICATION | NOVARTIS AG (CH) | 1996-11-07 | — | — | WO | claimed |
| WO-1995024393-A1 | NAPHTHALENE DERIVATIVES AS PROSTAGLANDIN I2 AGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-09-14 | — | — | WO | claimed |
| EP-0027330-B1 | PROCESS FOR THE PRODUCTION OF METHYLENEDICARBANILATES AND THE COMPOUNDS THUS OBTAINED | MITSUBISHI KASEI CORPORATION (JP) | 1984-12-12 | — | — | EP | claimed |
| US-4476317-A | HETEROPOLYMOLYBDIC ACID OR HETEROPOLYTUNGSTIC ACID | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1984-10-09 | — | — | US | claimed |
| EP-0027330-A1 | Process for the production of methylenedicarbanilates and the compounds thus obtained | MITSUBISHI KASEI CORPORATION (JP) | 1981-04-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210300954-A1 | IONIC TAGS FOR SYNTHESIS OF OLIGORIBONUCLEOTIDES | RNGTT, OSTC, DTYMK | NPSR1 768/4885ALDH1A1 3469/4885KMT2A 3121/4885 |
| US-20180072747-A1 | METHODS FOR THE CHEMICAL SYNTHESIS OF PYRROLE-LINKED BIVALENT COMPOUNDS, AND COMPOSITIONS THEREOF | PAICS, TET3, PIN1 | NPSR1 2711/4885ALDH1A1 3424/4885KMT2A 446/4885 |
| US-20190161491-A1 | METHODS FOR THE CHEMICAL SYNTHESIS OF PYRROLE-LINKED BIVALENT COMPOUNDS, AND COMPOSITIONS THEREOF | PAICS, TET3, PIN1 | NPSR1 2711/4885ALDH1A1 3424/4885KMT2A 446/4885 |
| US-20020052337-A1 | Composition and method for inhibiting platelet aggregation | P2RY11, P2RY12, P2RY13 | NPSR1 71/4885ALDH1A1 3933/4885KMT2A 4381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.